167 results
COVID-19 Coronavirus Disease 2019

Harvard Medical School from Bench to Bedside

#COVID19 #Coronavirus #Pathophysiology #Overview #Diagnosis
COVID-19 Coronavirus ... Disease 2019 ... Harvard Medical ... to Bedside #COVID19
Pharmacologic Treatment of Hyperthyroidism

#Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Pharmacologic Treatment ... Hyperthyroidism #Treatment #Management ... #Pharmacology # ... Medications #Comparison
COVID-19 Infection - Clinical Presentation and Disease Progression for Severe Cases

Via https://doi.org/10.1007/s00134-020-05967-x

#COVID19 #Hospitalization #Disease #Progression #Severe
COVID-19 Infection ... Presentation and Disease ... 020-05967-x #COVID19 ... Hospitalization #Disease ... Coronavirus #Diagnosis #Management
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Treatment Agents for COVID ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Factors for Severe Disease ... Laboratory Workup COVID ... Neuro/Sedation #COVID19 ... NonIntensivist #diagnosis #management
Multi-System Inflammatory Syndrome in Children (MIS-C) vs. Kawasaki Disease
CDC Case Definition for MIS-C;
 • < 21
Kawasaki Disease ... other reasons for disease ... • Positive COVID ... MISC #Kawasaki #Comparison ... peds #pediatrics #COVID19
COVID-19 Vaccines - Comparison Chart
 • Moderna - mRNA-1273 mRNA in lipid nanoparticle
 • Pfizer -
COVID-19 Vaccines ... - Comparison Chart ... MonicaGandhi9 #COVID19 ... #vaccines #comparison ... #table #pharmacology
This is an oversimplified, hypothetical model to think about time from symptom onset and stages of
and stages of disease ... in COVID-19. ... #COVID19 #COVID ... infectiousdisease #clinical #management
Medical Toxicology Antidote Card - American College of Medical Toxicology

#Pharmacology #Management #Toxicology #Antidotes #PocketCard #ACMT #Dosing
Medical Toxicology ... American College of Medical ... Toxicology #Pharmacology ... #Management #Toxicology